8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
2013 / Meta-analysis of prospective cohorts
A meta-analysis of six prospective cohort studies containing 314,864 individuals and 8,920 stroke cases assessed dietary fiber consumption. Comparing the highest against the lowest intake categories showed an inverse association with stroke risk (RR 0.87, 95% CI: 0.77-0.99). Dose-response evaluation linked each 10-g daily increase in fiber intake to an estimated 12% lower risk of stroke (RR 0.88, 95% CI: 0.79-0.97).
Shows an association, not proof of cause and effect.
Chen GC, Lv DB, Pang Z, et al. Eur J Clin Nutr, 2013. PMID 23073261
2013 / Systematic review
A systematic review evaluated 16 randomized controlled trials (1,062 patients) and 11 observational studies (831 patients) on Nordic walking. Nordic walking demonstrated benefits for resting heart rate, blood pressure, aerobic capacity, peak oxygen consumption, and overall quality of life compared to brisk walking, and surpassed jogging on select endpoints.
Tschentscher M, Niederseer D, Niebauer J Am J Prev Med, 2013. PMID 23253654
2013 / Meta-analysis of randomized controlled trials
A meta-analysis analyzed 21 randomized trials with 91,074 adults followed for an average of 43 months. Supplementation showed no effect on all-cause mortality (RR 0.98, 95% CI 0.94 to 1.02), vascular mortality (RR 1.01, 95% CI 0.93 to 1.09), or cancer mortality (RR 0.96, 95% CI 0.88 to 1.04). A non-significant trend toward reduced all-cause mortality occurred across primary prevention trials (RR 0.94, 95% CI 0.89 to 1.00).
Macpherson H, Pipingas A, Pase MP Am J Clin Nutr, 2013. PMID 23255568
2013 / Systematic review and meta-analysis
A meta-analysis of seventeen studies examined homocysteine and vitamin B12 levels among omnivores, vegetarians, and vegans. Across 3,230 participants, an inverse relationship was confirmed between circulating homocysteine and serum vitamin B12. Only two studies showed that vegan biomarker levels did not differ from those of omnivores, highlighting a tendency toward elevated homocysteine among individuals avoiding animal products.
NANO counterpoint →
Obersby D, Chappell DC, Dunnett A, et al. Br J Nutr, 2013. PMID 23298782
2013 / Systematic review and meta-analysis of RCTs
A systematic review and meta-analysis of 15 randomized controlled trials examined the effects of aerobic endurance training lasting at least 4 weeks on ambulatory blood pressure in 633 healthy adults. Overall, endurance training significantly reduced daytime systolic blood pressure by -3.2 mmHg (95% CI, -5.0 to -1.3) and daytime diastolic blood pressure by -2.7 mmHg (95% CI, -3.9 to -1.5). No effect was observed on night-time blood pressure.
Cornelissen VA, Buys R, Smart NA J Hypertens, 2013. PMID 23325392
2013 / Meta-analysis and narrative overview
Researchers conducted an overview and a meta-analysis of studies up to October 2012 examining meat consumption and risks of diabetes and complications. For type 2 diabetes, the pooled relative risk per 100 g was 1.15 (95% CI 1.07-1.24) for total meat, 1.13 (95% CI 1.03-1.23) for unprocessed red meat, and 1.04 (95% CI 0.99-1.33) for poultry. Per 50 g of processed meat, the pooled relative risk was 1.32 (95% CI 1.19-1.48). The review noted that evidence is strongest for type 2 diabetes, coronary heart disease, and stroke, with processed meat showing the strongest association with type 2 diabetes.
Shows an association, not proof of cause and effect.
Feskens EJ, Sluik D, van Woudenbergh GJ Curr Diab Rep, 2013. PMID 23354681
2013 / Meta-analysis of prospective cohorts
A meta-analysis evaluated the long-term health outcomes linked to low-carbohydrate diets across multiple observational cohorts. High low-carbohydrate scores were associated with increased all-cause mortality (RR 1.31, 95% CI 1.07-1.59 across 4 cohorts with 272,216 participants). In contrast, risks for cardiovascular mortality (RR 1.10, 95% CI 0.98-1.24) and cardiovascular incidence (RR 0.98, 95% CI 0.78-1.24) were not statistically significant.
Shows an association, not proof of cause and effect.
Noto H, Goto A, Tsujimoto T, et al. PLoS One, 2013. PMID 23372809
2013 / Randomized controlled trial and updated meta-analysis
Recovered data from the Sydney Diet Heart Study evaluated 458 men aged 30 to 59 years with recent coronary events. Replacing dietary saturated fat with safflower oil linoleic acid increased all-cause mortality (17.6% vs 11.8%; HR 1.62; 95% CI, 1.00-2.64), cardiovascular death (HR 1.70; 95% CI, 1.03-2.80), and coronary heart disease death (HR 1.74; 95% CI, 1.04-2.92). An updated meta-analysis showed non-significant trends toward increased cardiovascular disease mortality (HR 1.27; 95% CI, 0.98-1.65).
Ramsden CE, Zamora D, Leelarthaepin B, et al. BMJ, 2013. PMID 23386268
2013 / Meta-analysis of randomized controlled trials
A meta-analysis of 15 randomized controlled trials comprising 188,209 participants evaluated supplements containing vitamins C, E, or beta-carotene against placebo. Supplementation did not alter risks for major cardiovascular occurrences (RR 1.00; 95% CI, 0.96 to 1.03), myocardial infarction (RR 0.98; 95% CI, 0.92 to 1.04), or stroke (RR 0.99; 95% CI, 0.93 to 1.05). Furthermore, total mortality (RR 1.03; 95% CI, 0.98 to 1.07) and fatal cardiac events (RR 1.02; 95% CI, 0.97 to 1.07) were unchanged.
Ye Y, Li J, Yuan Z PLoS One, 2013. PMID 23437244
2013 / Systematic review and meta-analysis of prospective cohorts
A meta-analysis of eight prospective cohort studies evaluated dietary fiber intake and initial stroke incidence. Greater total dietary fiber intake was inversely associated with combined hemorrhagic and ischemic stroke risk (RR per 7 g/day 0.93, 95% CI 0.88-0.98; I2=59%). Intake of soluble fiber was not significantly linked to stroke risk reduction (RR per 4 g/day 0.94, 95% CI 0.88-1.01; I2=21%). Few data existed for insoluble fiber or food sources.
Shows an association, not proof of cause and effect.
Threapleton DE, Greenwood DC, Evans CE, et al. Stroke, 2013. PMID 23539529
2013 / Systematic review and meta-analysis of randomized trials
In a meta-analysis of 34 trials with 3,230 participants lasting at least four weeks, modest salt reduction (mean urinary sodium change -75 mmol/24 h) reduced systolic blood pressure by 4.18 mm Hg (95% CI -5.18 to -3.18) and diastolic blood pressure by 2.06 mm Hg (-2.67 to -1.45). Significant falls occurred in hypertensive individuals (-5.39/-2.82 mm Hg) and normotensive individuals (-2.42/-1.00 mm Hg). Salt reduction caused small increases in plasma renin activity, aldosterone, and noradrenaline, but no significant changes in lipid concentrations.
He FJ, Li J, Macgregor GA BMJ, 2013. PMID 23558162
2013 / Meta-analysis of trials
A meta-analysis of 39 primary trials investigated the lipid effects of garlic preparations. In individuals with total cholesterol above 200 mg/dL, treatment for more than 2 months reduced total cholesterol by 17 ± 6 mg/dL and LDL cholesterol by 9 ± 6 mg/dL. HDL cholesterol rose only slightly, whereas triglycerides showed no significant alteration.
Ried K, Toben C, Fakler P Nutr Rev, 2013. PMID 23590705
2013 / Systematic review and meta-analysis of randomized controlled trials
A meta-analysis of 34 randomized trials with 3,230 participants evaluated modest salt reduction lasting at least four weeks. Reducing 24-hour urinary sodium by 75 mmol lowered systolic blood pressure by 4.18 mmHg (95% CI: -5.18 to -3.18) and diastolic blood pressure by 2.06 mmHg (95% CI: -2.67 to -1.45). Blood pressure reductions occurred in hypertensive and normotensive individuals, alongside small increases in renin, aldosterone, and noradrenaline, but no significant changes in lipid levels.
He FJ, Li J, Macgregor GA Cochrane Database Syst Rev, 2013. PMID 23633321
2013 / Meta-analysis
In a meta-analysis of 14 studies, high egg consumption was associated with elevated risks of cardiovascular disease (pooled RR 1.19; 95% CI 1.02-1.38) and diabetes (RR 1.68; 95% CI 1.41-2.00). Among individuals with diabetes, cardiovascular risk was also higher for top versus bottom intake categories (RR 1.83; 95% CI 1.42-2.37). Each additional four eggs eaten per week was linked to higher risk for both cardiovascular disease and diabetes.
Li Y, Zhou C, Zhou X, et al. Atherosclerosis, 2013. PMID 23643053
2013 / Meta-analysis of randomized controlled trials
A meta-analysis of 13 randomized trials compared very-low-carbohydrate ketogenic diets with low-fat diets for at least 12 months. Assignment to ketogenic diets reduced body weight (weighted mean difference -0.91 kg; 95% CI -1.65 to -0.17; 1,415 patients), triglycerides, and diastolic blood pressure. Ketogenic diets also increased HDL-cholesterol (WMD 0.09 mmol/l; 95% CI 0.06 to 0.12; 1,257 patients) and LDL-cholesterol (WMD 0.12 mmol/l; 95% CI 0.04 to 0.20; 1,255 patients).
Bueno NB, de Melo IS, de Oliveira SL, et al. Br J Nutr, 2013. PMID 23651522
2013 / Meta-analysis of prospective studies
A meta-analysis examined 23 prospective studies including 1,430,141 participants and 7,960 hemorrhagic strokes. Higher total cholesterol was associated with lower risk of hemorrhagic stroke (RR 0.69, 95% CI 0.59-0.81), as was low-density lipoprotein cholesterol (RR 0.62, 95% CI 0.41-0.92). In contrast, high-density lipoprotein cholesterol was positively linked to intracerebral hemorrhage risk (RR 1.17, 95% CI 1.02-1.35).
Shows an association, not proof of cause and effect.
Wang X, Dong Y, Qi X, et al. Stroke, 2013. PMID 23704101
2013 / Meta-analysis of observational studies
A meta-analysis pooled findings from 22 studies evaluating adherence to a Mediterranean dietary pattern. Greater adherence was associated with reduced risk of stroke (RR 0.71, 95% CI 0.57-0.89), depression (RR 0.68, 95% CI 0.54-0.86), and cognitive impairment (RR 0.60, 95% CI 0.43-0.83). Moderate adherence was also linked to lower risk of depression and cognitive decline.
Shows an association, not proof of cause and effect.
NANO counterpoint →
Psaltopoulou T, Sergentanis TN, Panagiotakos DB, et al. Ann Neurol, 2013. PMID 23720230
2013 / Meta-analysis of prospective cohort studies
A meta-analysis of prospective observational studies evaluated the link between coffee intake and various mortality outcomes. Highest versus low coffee intake (≤1 cup/day) was associated with lower all-cause mortality across 23 studies (pooled RR 0.88; 95% CI 0.84-0.93) and across 19 smoking-adjusted cohorts (RR 0.87; 95% CI 0.82-0.93). CVD mortality was also lower per 1 cup/day increment (RR 0.98; 95% CI 0.95-1.00), while cancer mortality was not linked (RR 1.03; 95% CI 0.97-1.10).
Shows an association, not proof of cause and effect.
Malerba S, Turati F, Galeone C, et al. Eur J Epidemiol, 2013. PMID 23934579
2013 / Meta-analysis of observational studies
A meta-analysis of seven observational studies comprising 115,993 participants found that caffeine intake was not associated with atrial fibrillation risk (OR 0.92, 95% CI 0.82 to 1.04). In high-quality studies, caffeine was linked to a lower risk (OR 0.87, 95% CI 0.80 to 0.94), and low-dose intake specifically showed an inverse association (OR 0.85, 95% CI 0.78 to 0.92). Intake based solely on coffee also was not linked to atrial fibrillation.
Shows an association, not proof of cause and effect.
Caldeira D, Martins C, Alves LB, et al. Heart, 2013. PMID 24009307
2013 / Systematic review and meta-analysis of randomized controlled trials
A systematic review and meta-analysis evaluated randomized controlled trials (≥3 months) of lifestyle interventions combining diet, exercise, and at least one other component compared with standard care. Nine trials evaluated patients at risk for diabetes, and 11 evaluated patients with diabetes. Seven studies reported that lifestyle interventions decreased diabetes risk from the end of intervention up to 10 years later. In patients with diabetes, two trials found no improvement in all-cause mortality (risk ratio, 0.75 [95% CI, 0.53 to 1.06]), composite cardiovascular disease outcomes were too heterogeneous to pool, and one trial reported improved microvascular outcomes at 13-year follow-up. Most trials focused on surrogate measures.
Schellenberg ES, Dryden DM, Vandermeer B, et al. Ann Intern Med, 2013. PMID 24126648
2013 / Systematic review and meta-analysis of clinical trials
A systematic review and meta-analysis of 8 clinical trials evaluated the LDL-cholesterol-lowering efficacy of plant sterols/stanols given as capsules or tablets. Included trials lasted 4 to 6 weeks with doses ranging from 1.0 to 3.0 g/day taken primarily with main meals. Plant sterol/stanol supplements significantly decreased LDL-cholesterol concentrations by 12 mg/dL (0.31 mmol/L; 95% CI -0.39 to -0.23; P<0.000) compared with placebo, with no significant heterogeneity (I2=0%). There was no significant difference in LDL reduction between supplements (-12 mg/dL [-0.31 mmol/L]) and foods enriched with plant sterols/stanols (-12 mg/dL [-0.31 mmol/L]).
Amir Shaghaghi M, Abumweis SS, Jones PJH J Acad Nutr Diet, 2013. PMID 24144075
2013 / Systematic review of dietary surveys and population studies
A systematic review gathered data on total fat, SFA, and PUFA intake from national dietary surveys or population studies published from 1995 across 40 countries. Total fat intake ranged from 11.1 to 46.2% of energy intake (% E), SFA from 2.9 to 20.9% E, and PUFA from 2.8 to 11.3% E. Mean intakes met recommendations for total fat (20-35% E), SFA (<10% E), and PUFA (6-11% E) in 25, 11, and 20 countries, respectively. SFA intake correlated with total fat intake (r = 0.76, p < 0.01) but not with PUFA intake (r = 0.03, p = 0.84).
Shows an association, not proof of cause and effect.
Harika RK, Eilander A, Alssema M, et al. Ann Nutr Metab, 2013. PMID 24192557
2013 / Systematic review
A systematic review examined supplement trials in community-dwelling adults without known deficiencies. Across 24 high-quality studies (n = 324,653) evaluating single or paired nutrients, evidence of benefit or harm was unclear, although beta-carotene was linked to increased lung cancer risk in smokers. Two trials (n = 27,658) observed lower cancer incidence in men taking multivitamins for over a decade (unadjusted RR 0.93; 95% CI, 0.87 to 0.99), with no effect on cardiovascular disease or in women.
Fortmann SP, Burda BU, Senger CA, et al. Ann Intern Med, 2013. PMID 24217421
2013 / Meta-analysis of prospective studies
A meta-analysis of prospective studies evaluated vitamin C intake, blood levels, and stroke risk. High versus low dietary vitamin C intake was associated with reduced stroke risk (RR 0.81, 95% CI: 0.74 to 0.90; 11 studies), as was higher circulating vitamin C (RR 0.62, 95% CI: 0.49 to 0.79; 6 studies). Vitamin C supplements showed no statistically significant association with stroke (RR 0.83, 95% CI: 0.62 to 1.10; 3 studies).
Shows an association, not proof of cause and effect.
Chen GC, Lu DB, Pang Z, et al. J Am Heart Assoc, 2013. PMID 24284213